Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.528% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CCN(CC)CCOC(=O)C12CC3CC(CC(C3)C1)C2
b. COc1ccc(/C=C2\SC(=S)N(CCC(=O)NC3CCCC3)C2=O)cc1OC
c. CCOCCCNC(=O)c1ccccc1OC1CCN(S(C)(=O)=O)CC1
Answer: c. CCOCCCNC(=O)c1ccccc1OC1CCN(S(C)(=O)=O)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOCCCNC(=O)c1ccccc1OC1CCN(S(C)(=O)=O)CC1
CCOCCCNC(=O)c1ccccc1OC1CCN(S(C)(=O)=O)CC1
N-(3-ethoxypropyl)-2-(1-methylsulfonylpiperidin-4-yl)oxybenzamide